94 related articles for article (PubMed ID: 1390240)
1. Shedding of CD9 antigen by bone marrow cells from patients with acute lymphoblastic leukaemia.
Komada Y; Zhang SL; Zhou YW; Shibata T; Azuma E; Sakurai M
Br J Haematol; 1992 Aug; 81(4):526-9. PubMed ID: 1390240
[TBL] [Abstract][Full Text] [Related]
2. Shedding of CD9 antigen in acute lymphoblastic leukemia.
Komada Y; Sakurai M
Leuk Lymphoma; 1994 Feb; 12(5-6):365-72. PubMed ID: 8180600
[TBL] [Abstract][Full Text] [Related]
3. Shedding of CD9 antigen into cerebrospinal fluid by acute lymphoblastic leukemia cells.
Komada Y; Ochiai H; Shimizu K; Azuma E; Kamiya H; Sakurai M
Blood; 1990 Jul; 76(1):112-6. PubMed ID: 2364164
[TBL] [Abstract][Full Text] [Related]
4. The immunologic detection of minimal residual disease in acute leukemia.
Campana D; Coustan-Smith E; Janossy G
Blood; 1990 Jul; 76(1):163-71. PubMed ID: 1973061
[TBL] [Abstract][Full Text] [Related]
5. CD9 is an unreliable antibody for bone marrow purging.
Fort JA; Rios AM; Gross S; Janssen WE
Prog Clin Biol Res; 1990; 333():185-9. PubMed ID: 2408060
[TBL] [Abstract][Full Text] [Related]
6. CD9 antigen on acute non-lymphoid leukemia cells: preferential expression by promyelocytic (M3) subtype.
Ferrero D; Carlesso N; Gallo E; Pregno P; De Fabritiis P; Petti MC; Mandelli F
Leuk Res; 1991; 15(6):457-61. PubMed ID: 1861531
[TBL] [Abstract][Full Text] [Related]
7. [Expression of AC133 vs. CD34 in acute childhood leukemias].
Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
[TBL] [Abstract][Full Text] [Related]
8. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia.
Coustan-Smith E; Behm FG; Sanchez J; Boyett JM; Hancock ML; Raimondi SC; Rubnitz JE; Rivera GK; Sandlund JT; Pui CH; Campana D
Lancet; 1998 Feb; 351(9102):550-4. PubMed ID: 9492773
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a monoclonal IgM antibody for purging of bone marrow for autologous transplantation.
Zola H; Potter A; Neoh SH; Juttner CA; Haylock DN; Rice AM; Favaloro EJ; Kabral A; Bradstock KF
Bone Marrow Transplant; 1987 Feb; 1(3):297-301. PubMed ID: 3332140
[TBL] [Abstract][Full Text] [Related]
10. Characterization of rat NCA/CD9 cell surface antigen and its expression by normal and malignant neural cells.
Deissler H; Blass-Kampmann S; Kindler-Röhrborn A; Meyer HE; Rajewsky MF
J Neurosci Res; 1996 Mar; 43(6):664-74. PubMed ID: 8984196
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
[TBL] [Abstract][Full Text] [Related]
12. Minimal residual disease in acute lymphoblastic leukaemia--PCR analysis of immunoglobulin gene rearrangements.
Cole-Sinclair M; Foroni L; Wright F; Mehta A; Prentice HG; Hoffbrand AV
Leuk Lymphoma; 1993; 11 Suppl 2():49-58. PubMed ID: 8124233
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia.
Björklund E; Mazur J; Söderhäll S; Porwit-MacDonald A
Leukemia; 2003 Jan; 17(1):138-48. PubMed ID: 12529671
[TBL] [Abstract][Full Text] [Related]
14. Preparation of fibroblast-free cytotrophoblast cultures utilizing differential expression of the CD9 antigen.
Morrish DW; Shaw AR; Seehafer J; Bhardwaj D; Paras MT
In Vitro Cell Dev Biol; 1991 Apr; 27A(4):303-6. PubMed ID: 1856155
[TBL] [Abstract][Full Text] [Related]
15. Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome.
Griesinger F; Pirò-Noack M; Kaib N; Falk M; Renziehausen A; Troff C; Grove D; Schnittger S; Büchner T; Ritter J; Hiddemann W; Wörmann B
Br J Haematol; 1999 Apr; 105(1):241-55. PubMed ID: 10233388
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
J Clin Oncol; 1996 Oct; 14(10):2812-7. PubMed ID: 8874343
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD9 (p24) antigen on hematopoietic cells following treatment with phorbol ester.
Yasukawa M; Hato T; Inatsuki A; Kobayashi Y
Acta Haematol; 1988; 79(3):133-6. PubMed ID: 3128036
[TBL] [Abstract][Full Text] [Related]
18. Distribution of cell surface glycoprotein CD9 (P24) antigen on megakaryocyte lineage leukemias and cell lines.
Imamura N; Mtasiwa DM; Ota H; Inada T; Kuramoto A
Am J Hematol; 1990 Sep; 35(1):65-7. PubMed ID: 2389771
[TBL] [Abstract][Full Text] [Related]
19. Homotypic aggregation of pre-B leukemic cell lines by antibodies to VLA integrins correlates with their expression of CD9.
Letarte M; Seehafer JG; Greaves A; Masellis-Smith A; Shaw AR
Leukemia; 1993 Jan; 7(1):93-103. PubMed ID: 7678118
[TBL] [Abstract][Full Text] [Related]
20. Unique immunophenotype of acute promyelocytic leukaemia as defined by CD9 and CD68 antibodies.
Erber WN; Asbahr H; Rule SA; Scott CS
Br J Haematol; 1994 Sep; 88(1):101-4. PubMed ID: 7803230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
